全文获取类型
收费全文 | 87424篇 |
免费 | 6364篇 |
国内免费 | 1891篇 |
专业分类
耳鼻咽喉 | 503篇 |
儿科学 | 1714篇 |
妇产科学 | 1153篇 |
基础医学 | 10036篇 |
口腔科学 | 1559篇 |
临床医学 | 8385篇 |
内科学 | 13800篇 |
皮肤病学 | 1710篇 |
神经病学 | 5283篇 |
特种医学 | 1889篇 |
外国民族医学 | 9篇 |
外科学 | 7364篇 |
综合类 | 10691篇 |
现状与发展 | 8篇 |
一般理论 | 49篇 |
预防医学 | 8514篇 |
眼科学 | 993篇 |
药学 | 11503篇 |
27篇 | |
中国医学 | 3990篇 |
肿瘤学 | 6499篇 |
出版年
2024年 | 142篇 |
2023年 | 2914篇 |
2022年 | 4542篇 |
2021年 | 8960篇 |
2020年 | 6031篇 |
2019年 | 4919篇 |
2018年 | 4345篇 |
2017年 | 2942篇 |
2016年 | 2107篇 |
2015年 | 2487篇 |
2014年 | 4597篇 |
2013年 | 4138篇 |
2012年 | 3820篇 |
2011年 | 4187篇 |
2010年 | 3925篇 |
2009年 | 4086篇 |
2008年 | 3193篇 |
2007年 | 3930篇 |
2006年 | 3404篇 |
2005年 | 2774篇 |
2004年 | 1800篇 |
2003年 | 1706篇 |
2002年 | 1327篇 |
2001年 | 1116篇 |
2000年 | 1055篇 |
1999年 | 839篇 |
1998年 | 746篇 |
1997年 | 624篇 |
1996年 | 607篇 |
1995年 | 519篇 |
1994年 | 429篇 |
1993年 | 338篇 |
1992年 | 318篇 |
1991年 | 303篇 |
1990年 | 233篇 |
1989年 | 206篇 |
1988年 | 164篇 |
1987年 | 198篇 |
1986年 | 177篇 |
1985年 | 744篇 |
1984年 | 951篇 |
1983年 | 626篇 |
1982年 | 643篇 |
1981年 | 604篇 |
1980年 | 488篇 |
1979年 | 440篇 |
1978年 | 252篇 |
1977年 | 227篇 |
1976年 | 157篇 |
1975年 | 120篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
《Journal of microbiology, immunology, and infection》2021,54(4):748-751
IntroductionThe novel coronavirus disease (COVID-19) could cause a severe acute respiratory infectious disease, showing a high mortality rate of 12–45% among cases who required intensive care unit admission. COVID-19 pneumoniaPatients and methodsFor the purpose of identifying clinical manifestations and radiological findings of COVID-19 pneumonia, we reviewed all cases of COVID-19 pneumonia which were published by the homepage of the Japanese Association for Infectious Diseases from Feb 5 2020 until April 30 2020, including our cases. All patients were diagnosed based on positive results of the novel coronavirus-real-time RT-PCR with chest computed tomography (CT) findings.ResultsA total of 92 patients were enrolled in this study. The median age was 66 years (range 16–92 years). For all, 50 (54%) were males. The most common underlying disease was hypertension in 32 (36%). Any comorbidity was seen in 60 (67%). The mortality rate was 4 (6%). In terms of clinical symptoms on an initial visit, fever and cough were confirmed in 66 (72%) and 37 (40%). Forty-three (47%) had no respiratory symptoms. As for radiological findings by chest CT scan, ground-glass opacities (GGO)s, peripheral distribution, bilateral lung involvements were seen in 88 (96%), 76 (83%) and 78 (85%), respectively.ConclusionIt is difficult to diagnose as COVID-19 pneumonia due to poor respiratory symptoms. Chest CT findings typically show GGO, peripheral and bilateral shadows. Patients should have chest CT performed if suspected for early diagnosis and therapeutic intervention, resulting in a favorable outcome and prevention of secondary nosocomial transmitted infection. 相似文献
12.
《Journal of microbiology, immunology, and infection》2021,54(5):983-986
In an investigation of six anti-SARS-CoV-2 antibody kits with different target antigen and methodology, each kit showed comparable performance. As false-positive reactions occurred independently with different kits, specificity increased to 100% when pairs of kits were used. With three-kit combination, both sensitivity (99.1%) and specificity (100%) increased. 相似文献
13.
BackgroundTraditional Chinese medicine (TCM) has been proven to played a great important role on the treatment of COVID-19. As one of the drugs recommended in Chinese guidelines, Lianhua Qingwen Granules or Capsules (LQ) are widely used.This systematic review and meta-analysis amis to evaluate the clinical efficacy of LQ on the treatment of COVID-19.MethodsSeven databases (PubMed, EMBASE, CENTRAL, CNKI, VIP, CBM and Wanfang) were searched to include all appropriate clinical trials that explore the efficacy of LQ on the treatment of COVID-19.ResultA total of 3 trials including 245 COVID-19 patients were eventually enrolled.Compared with the control group,the LQ group showed great significant difference on reducing the rate of clinical change to severe or critical condition[RR = 0.38, 95 %CI (0.17,0.85), P < 0.05]and the fever time (SMD =-0.57,95 %CI (-0.96,-0.17), P<0.05),as well as the significant improvement on the disappearance rate of the clinical symptoms: fever [RR = 1.36,95 %CI (1.14,1.61), P < 0.05],cough[RR = 1.99,95 %CI (1.39,2.86), P < 0.05],fatigue[RR = 1.52,95 %CI (1.15,2.01), P < 0.05] and anhelation [RR = 4.18,95 %CI (1.99,8.81), P < 0.05], but no significance on expectoration[RR = 2.46,95 %CI (0.81,7.51), P < 0.05].ConclusionThe clinical application of LQ on the treatment of COVID-19 has significant efficacy in improving clinical symptoms and reducing the rate of clinical change to severe or critical condition. Nevertheless, due to the limited quantity and quality of the included studies, more and higher quality trials with more observational indicators are expected to be published. 相似文献
14.
Hannah C. Nordhues Anjali Bhagra Natya N. Stroud Jennifer A. Vencill Carol L. Kuhle 《Mayo Clinic proceedings. Mayo Clinic》2021,96(7):1907-1920
The coronavirus disease 2019 (COVID-19) pandemic has rapidly created widespread impacts on global health and the economy. Data suggest that women are less susceptible to severe illness. However, sex-disaggregated data are incomplete, leaving room for misinterpretation, and focusing only on biologic sex underestimates the gendered impact of the pandemic on women. This narrative review summarizes what is known about gender disparities during the COVID-19 pandemic and the economic, domestic, and health burdens along with overlapping vulnerabilities related to the pandemic. In addition, this review outlines recommended strategies that advocacy groups, community leaders, and policymakers should implement to mitigate the widening gender disparities related to COVID-19. 相似文献
15.
16.
目的 借助网络药理学的方法,探究两组王琦教授新冠肺炎预防方(简称预防方)预防新型冠状病毒肺炎(COVID-19)的分子靶点和机制。方法 通过TCMSP数据库检索并筛选其活性成分及其作用靶点,通过Uniprot数据库进行蛋白标准化处理。从Genecards数据库中以“Novel coronavirus pneumonia”为关键词搜索获取COVID-19的靶标,构建相交靶点韦恩图。通过cytoscape3.7.2构建PPI蛋白互作网络,寻找富集数目最多的靶点。通过R语言对预防方治疗COVID-19的靶点进行GO和KEGG富集分析,并绘制气泡图。结果 预防方与新冠肺炎相关靶点涉IL-6、TNF、CXCL8、VEGFA、MMP9;GO功能富集分析分别获得53、57条通路;27、29条KEGG相关信号通路。结论 王琦教授新冠肺炎预防方中的主要活性成分为槲皮素、山奈酚、木犀草素、β-谷甾醇、植物甾醇等,可能通过作用于IL-6、TNF、CXCL8、VEGFA、MMP9、CXCL8、IL10、CCL2、IL1B等靶点和介导TNF信号通路、T细胞受体信号通路、Toll样受体信号通路等发挥作用,从而促进免疫反应、炎症反应及细菌防御反应,预防COVID-19。 相似文献
17.
18.
《Vaccine》2022,40(44):6431-6444
This is a Brighton Collaboration case definition of thrombosis and thromboembolism to be used in the evaluation of adverse events following immunization, and for epidemiologic studies for the assessment of background incidence or hypothesis testing. The case definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of SARS-CoV-2 vaccines. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by selected expert reviewers prior to submission. 相似文献
19.
《Journal of infection and chemotherapy》2022,28(4):587-590
A 37-year-old man developed right ankle pain and swelling six days after being diagnosed with coronavirus disease (COVID-19). Despite conservative treatment, his ankle symptoms persisted. Magnetic resonance imaging and computed tomography showed synovial hypertrophy and bone erosion in the ankle. Following arthroscopic synovectomy, performed 69 days after the COVID-19 diagnosis, the pain improved significantly. The clinical course was consistent with that of reactive arthritis following severe acute respiratory syndrome coronavirus 2 infection. The pathological findings resembled rheumatoid nodules. The bone erosion may have originated from the inflammatory pathway, which resembles the mechanism of rheumatoid arthritis. 相似文献
20.